We studied the effect of phosphorothioate oligodeoxynucleothe evidence that mice carrying constructs encoding bcr-abl 
macrophage compartment) and to ODN modifications, might reduce the availability of these compounds to clonogenic cells and influence the response of these cells to AS ODN treatIntroduction ment. In those studies, the exposure time of CML cells to ODNs did not exceed 24 h, which is probably too short a The identification of several genes that confer a growth advanperiod to produce significant protein down-regulation and tage to neoplastic cells has provided the molecular basis for specific antisense effects in the small fraction of clonogenic a therapeutic strategy exploiting the ability of antisense oligocells embedded within a heterogeneous cell population. deoxynucleotides (ODNs) to inhibit gene expression. 1 One We have examined the effect of bcr-abl [S]ODNs on the such gene, the hybrid bcr-abl, is present in the great majority colony-forming ability of CML chronic phase primary cells; of chronic myelogenous leukaemia (CML) 2, 3 and is transcribed 16-mer and 26-mer ODNs were evaluated, using a 120 h into an 8.5-kb chimeric mRNA that generates a 210-kDa proincubation with daily addition of fresh compounds, on both tein (P210) with deregulated tyrosine kinase activity. 4, 5 bcrmononuclear and CD34-positive enriched cells. Under these abl genes are involved in the pathogenesis of CML, based on conditions, inhibition of Ph-positive colony formation was observed after 120 h of incubation in the majority of patients, at levels significantly higher than after a 24 h incubation per- 40 g/ml/day for 5 days produced, in the 35 cases evaluated, a mean colony recovery of 41.9% (±3.9) (s.e.m.) of that from After heating at 95°C for 10 min, 25 l of each sample (2 × 10 6 cells/lane) was loaded on to a 7.5% acrylamide gel, untreated samples. The mean recovery for the subgroup (17 patients) with the B2A2 junction was 37.3% ± 4.4; the mean electrophoresed and transferred to nitrocellulose (Micron Separations, Westboro, MA, USA). Filters were saturated in NET recovery for the B3A2 subgroup (18 patients) was 46.2% ± 6.4; such a difference between the two subgroups, buffer (150 mM NaCl, 50 mM Tris-Cl pH 7.5, 5 mM EDTA, 0.1% Triton X-100) plus 0.4% gelatin for 45 min and NET although suggestive of a more efficient targeting of the B2A2 junction, is not statistically significant. A difference of 18% buffer plus 2% non-fat dry milk for another 45 min and then incubated with anti-ABL antibody 14 as indicated. Filters were was found between the proportion of colonies recovered after treatment with the junction-mRNA-corresponding antisense (Jwashed five times with 0.25% Tween, 0.25% NP-40 in Trisbuffered saline (TBS). Bound proteins were detected using the sp AS) (41.9%) and colony recovery after treatment with the antisense not corresponding to the sample mRNA junction (Jenhanced chemiluminescence Western blotting detection system (Amersham, Arlington Heights, IL, USA). After stripping, nonsp AS) (59.9%); this difference was statistically significant (P = 0.0001). Nonspecific effect of ODNs on Ph-positive cells the filters were blotted with anti-human heat-shock protein (HSP) 72/73 (Oncogene Science, Manhasset, NY, USA), as a was evaluated comparing colony numbers after incubation with J-sp AS ODNs with that after incubation with J-nonsp AS control for protein amounts loaded.
ODNS or that derived from untreated sammples. Table 1 reports the differences (P = value) observed in the 35 patients evaluated: compared to the untreated samples, 22 cases Preparation of nuclear, cytoplasm and membrane fractions for DNA and protein isolation showed a significant reduction of colonies after treatment with J-sp AS ODNs; in six cases, a statistically significant difference was observed in comparison to treatment with J-nonsp AS To prepare nuclear extracts, cells were collected, washed twice in PBS, and then resuspended in 1.5 volumes of a buffer ODNs. In all cases, no significant reduction of colony number was seen after incubation with sense sequences (data not containing 10 mM Hepes pH 7.9, 1 mM EDTA, 60 mM KCl, 1 mM DTT, in the presence of protease inhibitors (1 mM shown). Seventeen cases were evaluated for the activity of [S]ODNs phenyl-methyl-sulfonyl-fluoride (PMSF), 2 g/ml aprotinin, 2 g/ml leupeptin, 1 g/ml pepstatin A). Deionized Noridet on CD34 + enriched cells; in 14/17 a significant difference was found between the number of colonies recovered after incu-P-40 was added to the cell suspension at a final concentration of 0.1% v/v and cells were disrupted using a Dounce homobation with the J-sp AS ODNs as compared to the untreated samples, confirmed in four cases by the difference between genizer (B-type pestle). The nuclear pellet was resuspended in 1.5 volumes of 20 mM Hepes pH 7.9, 0.4 M NaCl, 25% glythe colonies recovered after J-sp AS and J-nonsp AS treatment (Table 1 ). When we compared the effect of 26-mer ODNs on cerol, 1 mM EDTA in the presence of protease inhibitors, and DNA or nuclear proteins were obtained as described above.
mononuclear cells with that on CD34 + enriched cells on the 17 patients tested on both target cells, no differences were The cytoplasm fraction was then centrifuged at 12 000 r.p.m./15 min to pellet the cell membranes. Each fraction was found in the proportion of colonies recovered after treatment of mononuclear cells with J-sp AS ODNs (38.4% ± 5.2) as separately used for DNA and protein extraction as described above.
compared to the proportion recovered after treatment of CD34 + concentrated cells (34.1% ± 4.9). However, a greater specific effect of the AS ODNs was evident on CD34 + cells, being 22.8% (P = 0.0001) the difference between the proStatistical analysis portion of residual colonies found after treatment with J-sp AS ODNs and J-nonsp AS ODNs, as compared to a difference of Statistical significance of differences in the number of colonies or the percentage of inhibition in duplicate untreated samples 10.4% (P = 0.01) found after treatment of mononuclear cells (Figure 1 ). or sense and antisense-treated plates was determined by Student's t-test for unpaired or paired samples using a PC statistical Interestingly, the antiproliferative effect of J-sp AS ODNs on CD34 + enriched cells appeared to be dependent on the prosoftware package (Statview 512+, Brain Power, Calabras, CA, USA). P value Ͻ0.05 was judged to be of statistical signifiportion of CD34 + cells present in the samples. In the 11 cases in which enumeration of CD34 + cells was available after the cance.
Because in all the experiments the number of residual coldouble-step concentration, a correlation was found between the proportion of CD34 + cells and the inhibition of colonies onies after incubation with sense ODNs was similar to that of untreated samples, comparisons between antisense-and after 120 h incubation (r = 0.63; P = 0.039) (Figure 2) . Cases with the highest proportion of CD34 + cells were also those in sense-induced effects are not included in the tables. Linear 
Figure 2
Correlation between the proportion of CD34 + cells in the which the specific effect of the AS ODNs was more samples and clonogenic cell recovery after treatment with AS pronounced.
[S]ODNs. CD34 + cells were concentrated using a double-step procedure as described in the text; 26-mer [S]ODNs were used at concentration of 40 g/ml for 120 h.
Time-dependent effect of 26-mer As ODNs on CML chronic phase cells nificantly influenced by the prolonged incubation time, while the effect of the J-sp AS ODNs was highly enhanced. In 10 samples, we also investigated whether a 120 h incubation with 26-mer ODNs resulted in greater inhibition of colony formation and improved specificity as compared to incubations for 24 h. + cells; colony recovery from mononuclear cells exposed to J-sp AS vitro with 40 g/day of J-sp AS ODNs for 5 days. Clearly, the increase in the amount of cell-associated ODN correlated ODNs was similar to that found after treatment with J-nonsp AS ODNs after both 24 and 120 h of incubation. In contrast, with the days of incubation. Most of the cell-associated ODN was found in either the cytoplasmic or the nuclear fractions the effect of J-nonsp AS ODNs on CD34
+ cells was not sig- (Table 3) . Moreover, CML mononuclear cell colony formation. A mean recovery of mononuclear and CD34 + cells from eight normal bone mar-53.7% ± 3.8 was found after incubation with J-sp AS ODNs, row samples were incubated with 26-mer and 16-mer sense significantly lower (P = 0.0001) than that observed after incuand AS ODNs, using the same conditions as for CML cells. bation with the J-nonsp AS ODNs (73.1 ± 4.7). The mean As indicated by the number of colonies recovered after treatrecovery in the B2A2 subgroup (14 patients) was 47.7% ± 3.7; ment with ODNs, there was no toxic effect by the 16-mer and the mean recovery in the B3A2 subgroup (16 patients) was the 26-mer ODNs on normal clonogenic cell growth 59.9% ± 6.3; such a difference was not statistically significant, (Table 4) . but the higher responsiveness of the B2A2 subgroup is in agreement with the data obtained using 26-mer ODNs. In 16/30 cases, incubation with J-sp AS ODNs produced a sig-
Uptake of [S]ODNs by CD34
+ cells nificant colony inhibition as compared to the untreated cells and in eight cases this inhibition was junction-specific ( Table 2 . At the end of the incubation, purified reduction compared to treatment with J-nonsp AS ODNs ( Table 2 ). As observed with the 26-mer ODNs, the effect of CD34 + cells were directly used for DNA extraction. In contrast, the mononuclear cell population was used for the sorting 16-mer J-sp AS ODNs on mononuclear and CD34 + enriched cells was not significantly different (56.3% ± 3.9 of CD34 + cells subsequently processed for DNA extraction. The amount of DNA used for detection of intracellular ODNs vs 47.4% ± 4.8 residual colonies for mononuclear and CD34 + cells, respectively) on the 20 samples tested. However, the was adjusted to reflect equal cell numbers. As shown in Figure 6 , the amount of 16-mer B2A2 [S]ODNs associated effect of the bcr-abl AS ODNs was more specific on the CD34 + than on the mononuclear cells (14.1% and 24.3% with purified CD34 + cell fraction (lanes 2 and 4) is much higher than that associated with CD34 + cells sorted from the being the difference between J-nonsp and J-sp AS ODN recovery for mononuclear cells and CD34 + cells, respectively) mononuclear mixture (lanes 1 and 3) . These data clearly suggest that mononuclear cells are heterogenous in their ability ( Figure 5 ). /ml in 10 ml) were incubated for 72 h with 40 g/ml of 26-mer B2A2 AS ODNs. At the end of the incubation period, DNA was extracted from the membrane, and cytoplasm and nuclear fraction separated as described. 26 An equal volume (10 l) of cell extract was electroblotted on to a Nytran membrane and the resulting blot hybridized with ␥ 32 P B2A2 sense ODN. (c) p210 GAP protein was detected in 10 g of protein from the cytoplasmic and nuclear fraction by Western blot with the anti-human GAP rabbit serum as described. sense sequence (lane 1). In contrast, no hybridization band Table 4 Effect of 16-and 26-mer sense and antisense bcr-abl ODNs on normal mononuclear and CD34 + bone marrow cells showed a significant reduction of colony formation after treatment with J-sp AS ODNs. Down-regulation of p210 bcr-abl protein levels is apparent 72 h after [S]ODNs treatment, consistwas detected when the 16-mer B2A2 AS was hybridized with the 16-mer B3A2 sense sequence (lane 3). These results sugent with the relatively long (24-48 h) half-life of the protein.
15
Of the nine remaining cases, four had reduced p210 bcr-abl levgest cross-reactivity when 26-mer ODNs are used, but specific targeting of individual bcr-abl junctions by the 16-mer ODNs. els after incubation with J-sp AS ODNs as compared to the treatment with J-nonsp AS ODNs and to control K-562 cells (not shown); in five cases, the incubation with AS ODNs caused either a modest or a nonspecific effect on p210
bcr-abl
Evaluation of p210 bcr-abl expression after incubation of CML-CP with ODNs levels (not shown). In general, the effect of AS ODNs on p210 bcr-abl expression correlated with the inhibition observed in colony formation assays and reflected the variability of the Ten cases were studied for p210
bcr-abl expression after incubation with J-sp and J-nonsp AS ODNs for 120 h. Figure 8 observed antisense effects.
mechanisms other than specific targeting of bcr-abl junction has been postulated by different groups. 20, 21 In this study, we found an irrelevant antileukaemic effect of a 12-mer B2A2 AS ODN and a 12-mer two-base mismatched ODN, both containing the TAT motif, as compared to both the J-sp AS ODNs and the J-nonsp AS ODNs, as well as an absence of toxicity of [S]ODNs on normal bone marrow clonogenic cells. The possibility, therefore, that [S]ODNs act in an aptameric manner, interfering with functions required for bcr-abl-mediated in vitro cell transformation seems to be unlikely, at least when primary cells from patients with CML in chronic phase are used. It has also been postulated that [S]ODNs containing
Figure 8
Effect on clonogenic cells, the possible presence of residual normal clonogenic cells in CML patients at diagnosis and the possibility of bcr-abl non-rearranged colonies grown after treatment Discussion with bcr-abl AS ODNs, should be considered. In five cases, RNA from residual single colonies was isolated and the levels Antisense oligodeoxynucleotides that target the bcr-abl junction are ideally suited as antileukaemic agents in patients with of bcr-abl transcripts were evaluated by RT-PCR. The bcr-abl rearrangement was found in 100% of the residual colonies CML because of the role of the bcr-abl protein in the pathogenesis of CML and the possibility of interfering with the analysed (data not shown).
The 120 h incubation of mononuclear or CD34 + enriched expression of a leukaemia-specific product. In vitro and in vivo preclinical studies 8, 9, 16 have demonstrated the promise cells with AS [S]ODNs resulted in a significant increase in leukaemic clonogenic cell elimination as compared to the for the use of such compounds in clinical applications.
17,18
The most effective antileukaemic activity has been reported 24 h incubation; these results correlated with the time-dependent AS [S]ODNs uptake and confirmed that CD34 + cells are using bcr-abl AS ODNs on CML cell lines and on primary cells from patients in blastic phase; 8, 9 ,16 the mechanism(s) of a suitable target for AS ODNs treatment. Compared to the mononuclear cell fraction, this cell subpopulation appeared this preferential inhibition of blast cells remains largely unknown. The available data on the effects of bcr-abl AS to be more sensitive to AS [S]ODNs treatment; of equal importance, the effects were much more specific. Such increased ODNs on primary cells from patients in chronic phase indicate a modest inhibition of Ph-positive colony formation and sensitivity and specificity is probably due to a more efficient [S]ODN uptake by purified CD34 + cells (see below). In agreeevidence of cross-reactivity effect in some cases.
10,11 However, those data reflect experiments conducted in a small ment with this interpretation, there was good correlation between the proportion of CD34 + cells in the samples and number of cases, 19 or in which only some of the possible modalities of in vitro treatment were explored. In particular, clonogenic cell recovery after treatment with 26-mer oligomers. We used a double-step procedure (density gradient of the short incubation time (24 h) used in those studies, might account, at least in part, for the partial inhibition of CML col-1.065 g/ml followed by MoAbs and immunomagnetic beads), concentrating a median of 43% CD34 + cells. Because the ony formation. In the present study, we evaluated the effect of both 26-mer and 16-mer ODNs on patients with CML in presence of CD34 + cells in the samples seems to be critical for optimal inhibition of leukaemic cells, a greater elimination chronic phase, comparing the sensitivity of mononuclear cells to that of CD34 + enriched cells. In the 35 cases, an overall of Ph-positive clonogenic cells might be expected using more sensitive techniques such as fluorescence-activated cell sortrecovery of 41.9% ± 3.9 clonogenic cells was found when 26-mer J-sp AS ODNs were tested on mononuclear cells, coning to enrich for CD34 + progenitors. Down-regulation of the p210 bcr-abl protein is crucial to demonstrate the specificity of firming the heterogeneity of cell sensitivity to AS ODNs in patients in chronic phase. When the nonspecific effect of the the antileukaemic effect of AS ODNs, based on strong evidence that the bcr-abl gene product plays an essential role in AS ODNs was evaluated on several sub-groups, only 6/35 and 4/17 cases tested with 26-mer AS ODNs on mononuclear cells CML pathogenesis. It has been shown that p210
bcr-abl expression can be inhibited in Ph-positive cell lines using AS and on CD34 + cells, respectively, showed a significant greater reduction of clonogeneic cells after incubation with J-sp AS ODNs 9 or retrovirally transduced antisense sequence. 23 Our Western blotting analysis of p210 bcr-abl expression in chronic ODNs as compared to J-nonsp AS ODNs. However, when the 16-mer ODNs were used, 8/30 and 13/20 patients tested on phase cells from 10 CML cases after incubation with AS ODNs for 120 h revealed specific inhibition of p210 bcr-abl expression mononuclear and CD34 + cells, respectively, showed a specific sensitivity to ODNs. In general, 16-mer ODNs displayed in four cases. A good correlation, however, was found between colony an inhibitory effect on CML colony formation comparable to that of the 26-mer ODNs, but the specific effect was signifinumber and ability to down-regulate p210 bcr-abl expression, supporting the idea that the inhibition of colony formation cantly greater. These results were also confirmed by crosshybridization experiments which showed cross-reactivity reflects a specific antisense effect. It is not clear whether the heterogeneity found in chronic when 26-mer B2A2 antisense ODNs were hybridized with 26-mer B3A2 sense sequence, and no hybridization band when phase cells arises through selection based on biological characteristics of CML cells. Genetic abnormalities other than the 16-mer ODNs were used.
The possibility of inhibitory effects of bcr-abl AS ODNs by the Philadelphia chromosome rarely occur in CML chronic
